- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Sectors
Daily Deal Round Up: July 29, 2021
Carbon-neutral blockchain technology developer Core Scientific raised $54m from Celsius while autoimmune disease therapy developer Topas Therapeutics took a BIVF-backed round past $47m.
Jul 29, 2021Emerging Leaders Q&A – Ryota Suzuki, SIF & IGV
Q&A with Ryota Suzuki, senior investment manager, Sony Innovation Fund by IGV
Jul 29, 2021IgGenix initiates $25m series A1
Co-founded by Stanford researchers, IgGenix is working on therapies that address severe allergies.
Jul 29, 2021Tepha ticks acquisition box
Based on research originally conducted at MIT, Tepha has been purchased by BD for an undisclosed sum.
Jul 29, 2021Redwood to grow with $700m
Amazon Climate Pledge Fund has reinvested in the battery recycling services provider at a reported $3.7bn post-money valuation.
Jul 29, 2021Isar Aerospace increases series B payload
TU Munich spinout Isar Aerospace has added $75m to its series B round, bringing the round’s total to nearly $166m and its overall financing to more than $183m.
Jul 29, 2021Ring circles $117m series B
UPMC Enterprises has contributed to a $117m series B round for gene therapy developer Ring Therapeutics.
Jul 29, 2021Topas tops up series B
Topas Therapeutics has almost doubled its series B round to $48m thanks to an extension backed by all of its shareholders.
Jul 29, 2021DataRobot processes Algorithmia acquisition
OUP has exited Algorithmia following its acquisition by DataRobot for an undisclosed sum.
Jul 29, 2021DuoLingo brings in $521m IPO
CapitalG sold $36.3m of shares in an upsized offering for the language learning app developer, which saw its shares rise 36% on their first day.
Jul 29, 2021PsiQuantum crosses off $450m in funding
PsiQuantum has become the first unicorn in Imec.xpand’s portfolio as it fetched a valuation of more than $3bn.
Jul 29, 2021Embark passes series B test with $75m
Cornell-linked dog DNA test developer Embark Veterinary raised the capital in a round led by SoftBank Vision Fund 2 at a $700m post-money valuation.
Jul 29, 2021Featured Content
The CVC Funding Round DatabaseRealtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.The CVC Funding Round Database
Realtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.
CVC DirectoryFull details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.CVC Directory
Full details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.
Corporate venture building reportData from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomesCorporate venture building report
Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
